Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Development of gene expression signatures for psoriasis

ABSTRACT: Development of gene expression signatures for psoriasis

PROVIDER: PRJNA751566 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Development of gene expression signatures for psoriasis

Project description:To further explore the gene expression signatures in psoriatic, we have employed whole genome microarray expression profiling as a discovery platform to identify the potential genes that play a role in the pathogenesis of psoriasis. 3 psoriasis specimens were collected from patients with psoriasis and 3 normal skin were obtained from cosmetic surgeries as controls.The analysis identified a set of 4956 differentially expressed circRNAs，2194 significantly dysregulated lncRNAs，and 1725 discrepant mRNAs .Among all the differential expressed circRNAs, 3016 upregulated circRNAs and 1940 downregulated circRNAs were found in psoriatic lesions compared with normal healthy skin tissues.

2021-08-03 | GSE181318 | GEO

Development of gene expression signatures for NSCLC

Project description:Development of gene expression signatures for NSCLC

| PRJNA565445 | ENA

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

Project description:RATIONALE: Diagnostic imaging procedures, such as fludeoxyglucose F 18 PET, may be effective in detecting cancer or recurrence of cancer, or premalignant polyps. PURPOSE: This clinical trial is studying fludeoxyglucose F 18-PET imaging to see how well it works in determining protein and gene expression signatures in patients with premalignant polyps or colon cancer.

| 2045806 | ecrin-mdr-crc

Development of gene expression signatures for HCV infection

Project description:Development of gene expression signatures for HCV infection

| PRJNA976636 | ENA

Development of gene expression signatures for liver cirrhosis

Project description:Development of gene expression signatures for liver cirrhosis

| PRJNA510345 | ENA

Development of gene expression signatures for oral cancer

Project description:Development of gene expression signatures for oral cancer

| PRJNA610649 | ENA

Development of gene expression signatures for SL-13R

Project description:Development of gene expression signatures for SL-13R

| PRJNA705116 | ENA

Development of gene expression signatures for lncRNA MRPL23-AS1

Project description:Development of gene expression signatures for lncRNA MRPL23-AS1

| PRJNA563063 | ENA

Development of gene expression signatures for human liver fibrosis

Project description:Development of gene expression signatures for human liver fibrosis

| PRJNA808997 | ENA

Development of gene expression signatures for In-stent Restenosis

Project description:Development of gene expression signatures for In-stent Restenosis

| PRJNA755330 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data